Navigation Links
New Critical Path Report Highlights Research Needed to Foster,Generic Drug Development

ROCKVILLE, Md., May 2, 2007-The U.S. Food and Drug Administration (FDA) today issued the "Critical Path Opportunities for Generic Drugs" report identifying many of the unanswered scientific questions that impede the development of generic versions of commonly used drugs.

The report is part of FDA's Critical Path Initiative, established in 2004 to discern what challenges exist in moving a promising drug, biologic or device along the critical path from discovery, or proof of concept, to a marketable product. Solving these challenges will require the expertise and input of many groups, including scientists from universities, patient groups, government, industry, associations and other private organizations.

"This report pinpoints the barriers that are limiting the availability of additional generic drug options," said Gary Buehler, R.Ph., director, FDA's Office of Generic Drugs. "We hope these findings will encourage research collaboration, lower these barriers and accelerate access to safe and effective generic drugs."

Before they can be approved, generic drugs must have the same active ingredient, dosage form, strength, and conditions of use as the brand name drug. The drugs must also be absorbed at the same rate and in the same amount, a concept known as bioequivalence.

While straightforward tests of blood plasma levels are sufficient to demonstrate bioequivalence for most generic drug candidates, these common tests generally are not appropriate for certain drugs, including asthma inhalers, nasal sprays, and topical skin applications such as anti-fungal creams. As a result, few generic versions are available in these product categories, resulting in less competition and higher prices.

For example, generic drug products that contain the ozone-depleting substance chlorofluorocarbon
'"/>




Page: 1 2

Related medicine technology :

1. NIEHS Researchers Identify Enzyme Critical in DNA Replication
2. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
3. Critical Therapeutics Announces the Publication of Data for ZyfloCR (Zileuton) Extended-Release Tablets in the Journal of Asthma
4. Critical Therapeutics Announces the Publication of New Preclincial HMGB1 Data in Nature Immunology
5. Data Show SuperGens Multi-Targeted Tyrosine Kinase Inhibitor Suppresses Critical Double-Stranded DNA Repair Protein, Rad51
6. MIV Therapeutics Announces Pivotal Test Results Further Validating Company Stent Coatings Meet Critical FDA Fatigue Guidelines
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
9. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
Post Your Comments:
(Date:8/29/2014)... 29, 2014   Mast Therapeutics, Inc. ... today that Santosh Vetticaden, Chief Medical Officer and ... for personal reasons, in mid-September.  Edwin L. ... Aires Pharmaceuticals, which Mast acquired earlier this year, ... Company,s interim Chief Medical Officer.  Dr. Parsley previously ...
(Date:8/29/2014)... 29, 2014 Research and Markets ... Instrument Industry Report, 2014-2017" report to their offering. ... rising proportion of reimbursement for medical expenses, the Chinese ... its scale presenting a CAGR of 19.2% during 2009-2013. ... product segments of orthopedic instruments in China ...
(Date:8/29/2014)... 2014 Does your doctor know what you,re smoking?  ... recommended marijuana to the over 112,000 currently registered patients under ... of the other roughly 20,300+ active physicians listed with the ... it – even though a poll in February 2014 showed ... have tried it. "With marijuana legalization underway, ...
Breaking Medicine Technology:Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4China Orthopedic Instrument Industry Report, 2014-2017 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4
... 10, 2011 MAQUET Cardiovascular, a leading provider ... signed a three-year, dual-source contract with Premier Healthcare ... the Premier membership.  The contract includes the CS300 ... 50cc IABP Catheter, SENSATION® 7Fr. IABP Catheter and ...
... PRINCETON, N.J., Oct. 10, 2011 Pharmasset, Inc. (Nasdaq: ... two treatment arms to the ELECTRON trial of PSI-7977, ... chronic hepatitis C (HCV). The rapid and consistent antiviral ... to date provided the rationale for additional exploratory regimens ...
Cached Medicine Technology:MAQUET Cardiovascular Awarded Three-Year Contract From Premier Healthcare Alliance for Intra-Aortic Balloon Pumps 2MAQUET Cardiovascular Awarded Three-Year Contract From Premier Healthcare Alliance for Intra-Aortic Balloon Pumps 3Pharmasset Announces Further Expansion of ELECTRON Trial in Hepatitis C 2Pharmasset Announces Further Expansion of ELECTRON Trial in Hepatitis C 3Pharmasset Announces Further Expansion of ELECTRON Trial in Hepatitis C 4
(Date:8/31/2014)... Franklin, TN (PRWEB) August 31, 2014 ... continuing education course provides an in-depth analysis ... and treatment of selected shoulder complex conditions. Over ... utilizing case studies, clinical reasoning and problem solving ... algorithm-based examination format for the special tests of ...
(Date:8/31/2014)... 31 August 2014: Drinking tea reduces non-cardiovascular mortality by ... at ESC Congress today by Professor Nicolas Danchin from ... choose between tea or coffee it,s probably better to ... our way of life. Their effects on cardiovascular (CV) ... divergent results. We investigated the effects of coffee and ...
(Date:8/30/2014)... 2014: A new batteryless cardiac pacemaker based on ... was presented at ESC Congress 2014 today by ... not require battery replacement. , Mr Zurbuchen, a ... ARTORG, University of Bern, Switzerland, said: "Batteries are ... they reach a critically low energy level, physicians ...
(Date:8/30/2014)... MN (PRWEB) August 31, 2014 As ... in home renovation, especially spa style bathrooms and in-home ... (NASS) has observed an increase in interest not only ... the history, culture and health benefits of sauna. ... Finnleo , the North American Sauna Society provides a ...
(Date:8/30/2014)... 2014 UWDress.com, a distinguished wedding dress supplier, ... first range of fashionable outfits. Recently, the company has unveiled ... As an autumn special offer, all these brand new products ... , “We are excited to unveil the new and ... high quality products are available at low prices now. The ...
Breaking Medicine News(10 mins):Health News:North American Seminars Master Clinicians Advanced Shoulder Course Receives PT Continuing Education Course Approval in Georgia, Pennsylvania, Massachusetts and Virginia 2Health News:Drinking tea reduces non-CV mortality by 24 percent 2Health News:Drinking tea reduces non-CV mortality by 24 percent 3Health News:Batteryless cardiac pacemaker is based on automatic wristwatch 2Health News:As Interest in Saunas Increases, the North American Sauna Society Increases Outreach to Provide Education on History, Design, and Culture 2Health News:UWDress.com’s Beautiful Collection Of “Flowy Bridesmaid Dresses” Released 2
... See health and economic data like you,ve never ... statistics guru Hans Rosling will show how ... data. He will also illustrate how the convergence of ... countries into "Western" and "developing" categories an outdated concept.On ...
... Sports Medicine Provider Times Implementation to ... ALLENTOWN, Pa., May 21 Allscripts announced today that ... medicine in Pennsylvania,s Lehigh Valley, has selected the ... (EHR) and Practice Management (PM) ...
... , May 21 For the second year in ... fans to donate blood through the Red Cross by joining ... ) Red Cross Racing is a program designed to ... times they donate. Participants of this program can get points ...
... neuropathy than blood glucose levels, study suggests , , THURSDAY, ... levels of triglyceride fats are at increased risk of ... or damage of nerves that results in numbness, tingling ... researchers say. , A study by U.S. researchers ...
... A new study published online in Nature Immunology ... immunoglobulin (lg) alleles pair up in the nucleus at stages that ... and Igk) loci. Researchers led by Jane A. Skok ... of Medicine and a member of the NYU Cancer Institute, showed ...
... patient care with PDA-using nursing students in clinical ... illness, enlisting video games to improve analytical and ... myth-busting in advanced pain management courses are some ... at the first international Health Professions Education (HPE) ...
Cached Medicine News:Health News:Gapminder's Hans Rosling Brings Poverty, Health Data to Life at Wilson Center 2Health News:Coordinated Health Selects Allscripts Electronic Health Record and Practice Management to Improve Coordination of Patient Care 2Health News:Coordinated Health Selects Allscripts Electronic Health Record and Practice Management to Improve Coordination of Patient Care 3Health News:Coordinated Health Selects Allscripts Electronic Health Record and Practice Management to Improve Coordination of Patient Care 4Health News:Coordinated Health Selects Allscripts Electronic Health Record and Practice Management to Improve Coordination of Patient Care 5Health News:NASCAR Fans Boost Blood Donations; The American Red Cross Joins 3M and Greg Biffle to Kick off Season Two 2Health News:NASCAR Fans Boost Blood Donations; The American Red Cross Joins 3M and Greg Biffle to Kick off Season Two 3Health News:High Blood Fats Tied to Diabetic Nerve Loss 2Health News:NYU School of Medicine pathology researchers solve another mystery in B lymphocyte development 2Health News:Health Professions Education Conference features 'Headspace Theater,' serious gaming, PDAs 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: